跳至主要内容
临床试验/NCT06820606
NCT06820606招募中不适用

A Randomized Controlled Trial Comparing Efficacy and Cost Effectiveness of Water Vapour Thermal Therapy (Rezum) and Prostatic Urethral Lift (UroLift) in Men With Benign Prostatic Hyperplasia

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
1
主要终点
Changes in International Prostate Symptom Score (IPSS) at 12 months after treatment

研究概览

简要总结

This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Male ≥ 50 years Symptomatic BPH International prostate symptom score (IPSS) ≥13 Prostate volume 30-80ml

排除标准

  • •History or high suspicion of prostate cancer
  • •Current urinary tract infection
  • •Refractory urinary retention or post-void residual (PVR) ≥250 mL
  • •Intravesical prostatic protrusion (IPP)>10mm
  • •Prior prostate surgery
  • •Known or suspected allergy to nickel, titanium, or polyester/polypropylene
  • •Urethral stricture, meatal stenosis, bladder neck contracture
  • •Neurogenic bladder and/or sphincter abnormalities

研究组 & 干预措施

Rezum

Active Comparator

干预措施: Rezum (Device)

UroLift

Active Comparator

干预措施: UroLift (Device)

结局指标

主要结局

Changes in International Prostate Symptom Score (IPSS) at 12 months after treatment

时间窗: Baseline, 3 months, 6 months and 12 months after intervention

IPSS score ranging from 0-35 (the higher the worse)

次要结局

  • Post-op erectile function (MSHQ-EjD-SF)(Baseline, 3 months, 6 months and 12 months after intervention)
  • Hospital stays of procedure(From the time patient is hospitalised until the time he discharges)
  • Number of days on Foley's catheter or self-catheterization after operation(30 days after intervention)
  • Complication rate(30 days after intervention)
  • Post-op quality of life score (International Prostate QOL score)(Baseline, 3 months, 6 months and 12 months after intervention)
  • Post-op quality of life score (EQ5D-5L questionnaire)(Baseline, 3 months, 6 months and 12 months after intervention)
  • Change in voiding function in uroflowmetry (Maximum flow rate)(Baseline, 3 months, 6 months and 12 months after intervention)
  • Change in voiding function in uroflowmetry (Post void volume)(Baseline, 3 months, 6 months and 12 months after intervention)
  • Post-op erectile function (IIEF-EF)(Baseline, 3 months, 6 months and 12 months after intervention)
  • Unplanned readmission rate after operation in 30 days(30 days after intervention)
  • Cost of procedure and related hospitalization(At 12 months after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

CHIU Ka Fung Peter

Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验